321 related articles for article (PubMed ID: 23897695)
1. Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.
Moreno JD; Yang PC; Bankston JR; Grandi E; Bers DM; Kass RS; Clancy CE
Circ Res; 2013 Sep; 113(7):e50-e61. PubMed ID: 23897695
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC; Valdivia CR
Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
[TBL] [Abstract][Full Text] [Related]
4. Late sodium current associated cardiac electrophysiological and mechanical dysfunction.
Yu S; Li G; Huang CL; Lei M; Wu L
Pflugers Arch; 2018 Mar; 470(3):461-469. PubMed ID: 29127493
[TBL] [Abstract][Full Text] [Related]
5. Late I
Hwang J; Kim TY; Terentyev D; Zhong M; Kabakov AY; Bronk P; Arunachalam K; Belardinelli L; Rajamani S; Kunitomo Y; Pfeiffer Z; Lu Y; Peng X; Odening KE; Qu Z; Karma A; Koren G; Choi BR
Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e006875. PubMed ID: 32628505
[TBL] [Abstract][Full Text] [Related]
6. A computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late Na+ current.
Yang PC; Song Y; Giles WR; Horvath B; Chen-Izu Y; Belardinelli L; Rajamani S; Clancy CE
J Physiol; 2015 Mar; 593(6):1429-42. PubMed ID: 25545172
[TBL] [Abstract][Full Text] [Related]
7. Balance Between Rapid Delayed Rectifier K
Hegyi B; Chen-Izu Y; Izu LT; Rajamani S; Belardinelli L; Bers DM; Bányász T
Circ Arrhythm Electrophysiol; 2020 Apr; 13(4):e008130. PubMed ID: 32202931
[TBL] [Abstract][Full Text] [Related]
8. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy.
Bengel P; Ahmad S; Sossalla S
Curr Heart Fail Rep; 2017 Jun; 14(3):179-186. PubMed ID: 28455610
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.
Chorin E; Hu D; Antzelevitch C; Hochstadt A; Belardinelli L; Zeltser D; Barajas-Martinez H; Rozovski U; Rosso R; Adler A; Benhorin J; Viskin S
Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733495
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.
Wu L; Shryock JC; Song Y; Li Y; Antzelevitch C; Belardinelli L
J Pharmacol Exp Ther; 2004 Aug; 310(2):599-605. PubMed ID: 15031300
[TBL] [Abstract][Full Text] [Related]
13. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.
Wu L; Ma J; Li H; Wang C; Grandi E; Zhang P; Luo A; Bers DM; Shryock JC; Belardinelli L
Circulation; 2011 Apr; 123(16):1713-20. PubMed ID: 21482963
[TBL] [Abstract][Full Text] [Related]
14. Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Wu L; Rajamani S; Li H; January CT; Shryock JC; Belardinelli L
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1048-57. PubMed ID: 19592609
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.
Du C; Zhang Y; El Harchi A; Dempsey CE; Hancox JC
J Mol Cell Cardiol; 2014 Sep; 74(100):220-30. PubMed ID: 24877995
[TBL] [Abstract][Full Text] [Related]
16. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Song Y; Shryock JC; Wu L; Belardinelli L
J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.
Estacion M; Waxman SG; Dib-Hajj SD
Mol Pain; 2010 Jun; 6():35. PubMed ID: 20529343
[TBL] [Abstract][Full Text] [Related]
19. The antiarrhythmic effects of ranolazine.
Foster NJ; Haines DE
Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
[TBL] [Abstract][Full Text] [Related]
20. Is ranolazine an antiarrhythmic drug?
Eckhardt LL; Teelin TC; January CT
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1989-91. PubMed ID: 18375723
[No Abstract] [Full Text] [Related]
[Next] [New Search]